Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Reich

Showing results (211-220 of 316) with videos related to

Pageof 32
Sort By:
Postepy Dermatologii I Alergologii|September 12, 2022
Effectiveness of infliximab biosimilars in the treatment of moderate to severe chronic plaque psoriasis: experience of real-world data from the register of the program "Treatment of moderate and severe forms of plaque psoriasis (B.47)" of the National Health Fund in PolandWitold Owczarek, Irena Walecka, Agnieszka Nowakowska, et al.
Dermatologic Therapy|April 1, 2022
Comparative effectiveness of adalimumab versus ustekinumab in the treatment of severe chronic plaque psoriasis: The results based on data from the program "treatment of moderate and severe forms of plaque psoriasis (B.47)" of the National Health Fund in PolandWitold Owczarek, Agnieszka Nowakowska, Irena Walecka, et al.
Acta Dermatovenerologica Alpina, Pannonica, Et Adriatica|November 6, 2007
Skin involvement in highly malignant non-Hodgkin lymphomas of childhood and adolescenceAdam Reich, Grazyna Wróbel, Bernarda Kazanowska, et al.
Journal of Clinical Medicine|March 17, 2025
Inflammation-Related Markers in Pediatric Psoriasis: Resistin as a Potential Marker of Psoriasis SeverityMagdalena Szczegielniak, Aleksandra Lesiak, Adam Reich, et al.
Current Medical Research and Opinion|May 16, 2022
Efficacy, quality of life, and treatment satisfaction: an indirect comparison of calcipotriol/betamethasone dipropionate cream versus foam for treatment of psoriasisAdam Reich, Johan Selmer, Jordi Galván, et al.
Journal of Biophotonics|June 22, 2025
The Utility of Fourier Transform Infrared Spectroscopy (FTIR) for Detecting Exercise-Induced Changes in the Human Hand EpidermisPaweł Król, Zbigniew Obmiński, Adam Reich, et al.
Dermatology and Therapy|June 27, 2021
Multifocal Pyoderma Gangrenosum with an Underlying Hemophagocytic Lymphohistiocytosis: Case Report and the Review of the LiteratureAleksandra Opalińska, Dominika Kwiatkowska, Adrian Burdacki, et al.
Postepy Dermatologii I Alergologii|May 24, 2024
Awareness of people using municipal swimming pools about the prevention, symptoms, and treatment of athlete's foot and onychomycosis before COVID-19Hanna Cisoń, Paulina Kostrzewska, Natalia Łątka, et al.
Dermatology and Therapy|July 25, 2023
Calcipotriene and Betamethasone Dipropionate PAD-Cream Demonstrates Greater Treatment Efficacy in Patients with Moderate-to-Severe Psoriasis Compared to Topical Suspension/Gel: A Subgroup Analysis of Two Phase 3 StudiesLinda Stein Gold, Andreas Pinter, April Armstrong, et al.
Scientific Reports|March 8, 2017
Large-scale human skin lipidomics by quantitative, high-throughput shotgun mass spectrometryTomasz Sadowski, Christian Klose, Mathias J Gerl, et al.
Pageof 32

Showing results (211-220 of 316) with videos related to

Sort By:
Pageof 32
Postepy Dermatologii I Alergologii|September 12, 2022
Effectiveness of infliximab biosimilars in the treatment of moderate to severe chronic plaque psoriasis: experience of real-world data from the register of the program "Treatment of moderate and severe forms of plaque psoriasis (B.47)" of the National Health Fund in PolandWitold Owczarek, Irena Walecka, Agnieszka Nowakowska, et al.
Dermatologic Therapy|April 1, 2022
Comparative effectiveness of adalimumab versus ustekinumab in the treatment of severe chronic plaque psoriasis: The results based on data from the program "treatment of moderate and severe forms of plaque psoriasis (B.47)" of the National Health Fund in PolandWitold Owczarek, Agnieszka Nowakowska, Irena Walecka, et al.
Acta Dermatovenerologica Alpina, Pannonica, Et Adriatica|November 6, 2007
Skin involvement in highly malignant non-Hodgkin lymphomas of childhood and adolescenceAdam Reich, Grazyna Wróbel, Bernarda Kazanowska, et al.
Journal of Clinical Medicine|March 17, 2025
Inflammation-Related Markers in Pediatric Psoriasis: Resistin as a Potential Marker of Psoriasis SeverityMagdalena Szczegielniak, Aleksandra Lesiak, Adam Reich, et al.
Current Medical Research and Opinion|May 16, 2022
Efficacy, quality of life, and treatment satisfaction: an indirect comparison of calcipotriol/betamethasone dipropionate cream versus foam for treatment of psoriasisAdam Reich, Johan Selmer, Jordi Galván, et al.
Journal of Biophotonics|June 22, 2025
The Utility of Fourier Transform Infrared Spectroscopy (FTIR) for Detecting Exercise-Induced Changes in the Human Hand EpidermisPaweł Król, Zbigniew Obmiński, Adam Reich, et al.
Dermatology and Therapy|June 27, 2021
Multifocal Pyoderma Gangrenosum with an Underlying Hemophagocytic Lymphohistiocytosis: Case Report and the Review of the LiteratureAleksandra Opalińska, Dominika Kwiatkowska, Adrian Burdacki, et al.
Postepy Dermatologii I Alergologii|May 24, 2024
Awareness of people using municipal swimming pools about the prevention, symptoms, and treatment of athlete's foot and onychomycosis before COVID-19Hanna Cisoń, Paulina Kostrzewska, Natalia Łątka, et al.
Dermatology and Therapy|July 25, 2023
Calcipotriene and Betamethasone Dipropionate PAD-Cream Demonstrates Greater Treatment Efficacy in Patients with Moderate-to-Severe Psoriasis Compared to Topical Suspension/Gel: A Subgroup Analysis of Two Phase 3 StudiesLinda Stein Gold, Andreas Pinter, April Armstrong, et al.
Scientific Reports|March 8, 2017
Large-scale human skin lipidomics by quantitative, high-throughput shotgun mass spectrometryTomasz Sadowski, Christian Klose, Mathias J Gerl, et al.
Pageof 32